. Author manuscript; available in PMC: 2014 May 13.

Published in final edited form as: Kidney Int. 2010 Nov 17;79(5):538–545. doi: 10.1038/ki.2010.458

Table 2. Blood Chemistry.

Group	Days after EG Treatment	Albumin (g/dl)	Creatinine (mg/dl)	BUN (mg/dl)
Untreated Control	7 (n=6)	4.2±0.305	0.6±0.577	18.3±2.870
	14 (n=6)	4.5±0.556	0.8±0.115	20.6±2.084
	21 (n=6)	4.6±0.519	0.7±0.100	18.1±0.500
EG-Treated control	7 (n=6)	3.8±0.070	0.6±0.070	16.9±3.110
	14 (n=4)	3.5±0.173^**	0.6±0.141	24.6±15.90
	21 (n=6)	3.8±0.273^*	0.6±0.044	14.5±1.134
EG+PGG (4 mg/kg)	7 (n=6)	3.9±0.305	0.5±0.057	17.6±4.650
	14 (n=5)	3.8±0.298	0.6±0.050	19.2±4.860
	21 (n=6)	4.1±0.597	0.6±0.173	19.2±7.947
EG+PGG (20 mg/kg)	7 (n=6)	4.0±0.353	0.6±0.141	19.5±2.330
	14 (n=6)	3.7±0.125^*	0.6±0.057	15.2±2.610
	21 (n=5)	4.2±0.714	0.7±0.057	14.0±1.997

Abbreviations: BUN, blood urea nitrogen; EG, ethylene glycol; PGG, 1,2,3,4,6-penta-O-galloyl-b-D-glucose.

Mean±s.d.

P<0.05 and

^**

P<0.01 versus untreated control, two-way analysis of variance followed by post hoc analysis.